← NovoCure Ltd
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $99.8m | $78.6m | $140.6m | $177.3m | $234.7m | $208.8m | $115.3m | $240.8m | $163.8m | $93.5m | |
| Inventory, Net | $25.5m | $22.0m | $22.6m | $23.7m | $27.4m | $24.4m | $29.4m | $38.2m | $35.1m | $41.1m | |
| Assets, Current | $261.9m | $245.1m | $321.4m | $439.9m | $999.4m | $1.1b | $1.1b | $1.0b | $1.1b | $646.7m | |
| Property, Plant and Equipment, Net | $9.8m | $9.0m | $8.4m | $9.3m | $11.4m | $22.7m | $32.7m | $51.5m | $77.7m | $77.6m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $17.6m | $19.0m | $18.3m | $23.6m | $34.8m | $27.1m | $47.3m | |
| Other Assets, Noncurrent | $1.5m | $2.0m | $2.9m | $4.9m | $10.9m | $12.1m | $11.2m | $14.0m | $14.6m | $10.6m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $6.3m | $29.6m | $36.5m | $58.9m | $96.7m | $93.6m | $86.3m | $61.2m | $74.2m | $89.4m | |
| Assets | $282.1m | $265.3m | $339.8m | $479.4m | $1.1b | $1.1b | $1.2b | $1.1b | $1.2b | $804.3m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $4.6m | $6.5m | $6.7m | $5.8m | $8.2m | $7.9m | $11.7m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $14.1m | $14.3m | $13.0m | $18.8m | $27.4m | $20.0m | $41.6m | |
| Deferred Revenue, Noncurrent | — | — | $9.9m | — | — | — | — | — | — | — | |
| Long-term Debt, Excluding Current Maturities | $96.2m | $97.3m | $149.3m | $149.4m | $429.9m | $562.2m | $565.5m | $568.8m | $97.3m | $195.0m | |
| Liabilities, Current | $36.9m | $50.2m | $64.6m | $86.3m | $113.6m | $142.6m | $158.8m | $179.1m | $756.4m | $223.2m | |
| Deferred Income Tax Liabilities, Net | — | — | — | $0 | — | — | — | — | — | — | |
| Other Liabilities, Noncurrent | $4.0m | $1.7m | $1.1m | $222k | $337k | $166k | $148k | $18k | $18k | — | |
| Liabilities | $139.7m | $151.7m | $227.5m | $261.7m | $575.5m | $729.0m | $750.5m | $783.6m | $880.6m | $463.9m | |
| Commitments and Contingencies | $0 | $0 | $0 | — | — | — | — | — | — | — | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Additional Paid in Capital | $664.2m | $697.2m | $757.3m | $871.4m | $1.1b | $1.1b | $1.2b | $1.4b | $1.5b | $1.6b | |
| Retained Earnings (Accumulated Deficit) | ($519.9m) | ($582.3m) | ($643.7m) | ($650.9m) | ($631.1m) | ($685.9m) | ($778.5m) | ($985.5m) | ($1.2b) | ($1.3b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($1.9m) | ($1.3m) | ($1.4m) | ($2.8m) | ($3.8m) | ($3.2m) | ($2.4m) | ($5.5m) | ($5.5m) | ($3.4m) | |
| Stockholders' Equity Attributable to Parent | $142.3m | $113.6m | $112.3m | $217.8m | $476.5m | $410.5m | $441.2m | $362.5m | $360.2m | $340.5m | |
| Liabilities and Equity | $282.1m | $265.3m | $339.8m | $479.4m | $1.1b | $1.1b | $1.2b | $1.1b | $1.2b | $804.3m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.